Literature DB >> 21053063

Genetic characterization of the Korean LATC06 rinderpest vaccine strain.

Jung-Yong Yeh1, Chang-Hee Kwoen, Wooseog Jeong, Hye-Young Jeoung, Hee Soo Lee, Dong-Jun An.   

Abstract

We sequenced the genome of LATC06 generated by in vitro passage in Vero cells of the lapinized-avianized (LA) strain and compared its sequence to those of other rinderpest viruses. The LATC06 genome consists of 15882 nucleotides. Its transcriptional regulatory control sequences (TRSs) at gene boundaries are identical to those of the Kabete O strain. Cleavage sites for generating F1/F2 proteins were identified in the same amino acid position (aa 108) as F proteins in LATC06, L13, RBT1, Kabete O, and RBOK strains. There are three predicted N-glycosylation sites of H proteins in LA (Japan) and LATC06 strains. The six epitopes of H protein in the LA (Japan) strain that elicit immunodominant humoral responses are also found in the LATC06 strain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21053063     DOI: 10.1007/s11262-010-0543-y

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  17 in total

1.  Avianization of lapinized rinderpest virus.

Authors:  J NAKAMURA; T MIYAMOTO
Journal:  Am J Vet Res       Date:  1953-04       Impact factor: 1.156

2.  Studies with rinderpest virus in tissue culture. III. The stability of cultured virus and its use in virus neutralization tests.

Authors:  W PLOWRIGHT; R D FERRIS
Journal:  Arch Gesamte Virusforsch       Date:  1962

3.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

4.  Nucleotide sequence comparisons of the fusion protein gene from virulent and attenuated strains of rinderpest virus.

Authors:  S A Evans; M D Baron; R W Chamberlain; L Goatley; T Barrett
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

5.  Identification of immunodominant neutralizing epitopes on the hemagglutinin protein of rinderpest virus.

Authors:  Makoto Sugiyama; Naoto Ito; Nobuyuki Minamoto; Seiichi Tanaka
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Molecular cloning and sequence analysis of the phosphoprotein (P) gene of the lapinized rinderpest virus.

Authors:  K Nakamura; K Iwatsuki; Y Izumiya; Y Nishimura; K Ohashi; T Mikami; C Kai
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

7.  Molecular properties of the matrixprotein(M) gene of the lapinized rinderpest virus.

Authors:  M Shiotani; R Miura; K Fujita; C Wakasa; M Uema; C Kai
Journal:  J Vet Med Sci       Date:  2001-07       Impact factor: 1.267

8.  The role of the amino terminus of F1 of the Newcastle disease virus fusion protein in cleavage and fusion.

Authors:  T Morrison; C McQuain; T Sergel; L McGinnes; J Reitter
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

9.  Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity.

Authors:  M S Collins; J B Bashiruddin; D J Alexander
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes.

Authors:  M D Baron; A C Banyard; S Parida; T Barrett
Journal:  J Gen Virol       Date:  2005-04       Impact factor: 3.891

View more
  2 in total

1.  Complete genome analysis of three live attenuated Rinderpest virus vaccine strains derived through serial passages in different culture systems.

Authors:  Hye-Young Jeoung; Myoung-Heon Lee; Jung-Yong Yeh; Ji-Ae Lim; Seong-In Lim; Jae-Ku Oem; Jae-Young Song; Won-Ha Lee; Jong-Hwan Park; Dong-Jun An
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

2.  Full genome sequencing of archived wild type and vaccine rinderpest virus isolates prior to their destruction.

Authors:  Simon King; Paulina Rajko-Nenow; Honorata M Ropiak; Paolo Ribeca; Carrie Batten; Michael D Baron
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.